• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Venlafaxine
    5 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Efexor XR
    Pfizer
    RX
    partial basket chart
    Efexor XR

    SNRI. Venlafaxine (HCl) 75 mg, 150 mg.
    E.R CAPS.: 28. Major depress. Episodes: The recomm. starting dose for prolong. release venlafaxine is 75 mg×1/d. Pts. not respond. to the init. 75 mg/d dose may benefit from dose incr. up to a max. dose of 375 mg/d. Dosage incr. can be made at interv. of 2 wks. or more. If clinic. warranted due to sympt. sever., dose incr. can be made at more freq. interv., but not less than 4 d. Contin. for at least 6 mnths. follow. remiss.
    GAD: The recomm. starting dose for prolong. rel. venlafaxine is 75mg×1/d. Pts. not respond. to the init. 75 mg/d dose may benefit from dose incr. up to a max. dose of 225 mg/d. Dosage incr. can be made at interv. of 2 wks. or more.
    SAD: The recomm. dose for prolong. rel. venlafaxine is 75mg×1/d. There is no evidence that higher doses confer any addit. benefit.
    However, in individ. pts. not respond. to the init. 75 mg×1/d, incr. up to a max. dose of 225 mg/d may be consid. Dosage incr. can be made at interv. of 2 wks. or more.
    For the tmt. of depress. Mainten. of recur. depress. Generalized anxiety Disord. (GAD) - short term & long-term. Social anxiety Disord. (SAD).
    C/I: Hypersens. Concom. tmt. with irrevers. MAOIs. Venlafaxine must not be initiat. for at least 14 d after discont. of tmt. with an irrevers. MAOI. Venlafaxine must be discont. for at least 7 d before starting tmt. with an irrevers. MAOI.

    Venla
    Unipharm
    RX
    partial basket chart
    Venla

    SNRI. Venlafaxine (as HCl) 37.5 mg, 75 mg.
    TABS: 28. 2 tabs dly.
    Depression.
    C/I: Hypersens., pregn., lact., concur. use
    MAOI’s. See lit.

    Venlafaxine XR Teva
    Teva
    RX
    partial basket chart
    Venlafaxine XR Teva

    SNRI. Venlafaxine (HCl) 75, 150 mg.
    E.R. TABS: 30. Initial: 75 mg dly in single
    dose; for non-responders: Incr. up to
    225 mg dly in dly increments of up to
    75 mg at intervals of not less than 4
    days. Re-ass. regular. to evaluat.
    benefit of long term ther. Hepat.
    impair: Reduce init. dose by 50%. Ren.
    impair: Reduce total dly dose by
    25-50%. Pts. on hemodialys: Reduce by
    50%, withhold until dialys. tmt
    complet. (4 hrs). Elderly: No dos. adjust. needed. Care when incr. dose. Maint./
    extend. tmt: Perform period. evaluat.
    Discont: Taper grad., monitor pt.
    Switch. to/from MAOI: Allow at least 14
    days between discont. MAOI and
    initiat. of ther. Allow at least 7 days of
    discont. ther. bef. start tmt. with MAOI.
    Tmt. depress., maint. recurr. depress,
    GAD, short/long term SAD.
    C/I: Known hypersens., concom. use
    with MAOIs.

    Viepax 37.5 mg, 75 mg
    Dexcel
    RX
    partial basket chart
    Viepax 37.5 mg, 75 mg

    SNRI. Venlafaxine 37.5, 75 mg.
    TABS: 28. With food. Initial: 75 mg/day in 2 divided doses; non responders: may incr. up to 375mg/day at intervals of not less than 2 weeks. If clinically warranted due to symptoms severity, dose may be increased at more frequent intervals but not less than 4 days. See lit. Hepatic/renal impair.;elderly/ children and adolescents; maint. tmt./discontinuation: See lit.
    Treatment of depression.
    C/I: Hypersens. to active substance or excipients. Concomitant treatment with irreversible MAOIs. Must not be initiated for at least 14 days after discontinuation of tmt. with an irreversible MAOI. Must be discontinued for at least 7 days before starting tmt. with irreversible MAOI. See lit.

    Viepax XR 75 mg, 150 mg
    Dexcel
    RX
    partial basket chart
    Viepax XR 75 mg, 150 mg

    SNRI. Venlafaxine (HCl) 75, 150 mg.
    S.R. CAP.: 30. Initial: 75 mg 1 × dly; non responders: Depression: may incr. up to 375mg dly at intervals of not less than 2 weeks. If clinically warranted due to symptoms severity, dose may be increased at more frequent intervals but not less than 4 days. See lit.
    GAD, SAD: Incr. up to 225 mg dly at intervals not less than 2 weeks: See lit.
    Hepat./ren. impair./elderly/ children and adolescents: See lit.
    Discont: grad. reduced, monitor pt. See lit.
    Depression; maint. of recurr. depress; GAD- short/long term; SAD.
    C/I: Hypersens.; concom. use with irreversible MAOI's (at least 14 days between discount. irreversible MAOI and initiat. ther.; at least 7 days of discont. ther. bef. start tmt. with irreversible MAOI); See lit.

    CLOSE